At close: January 3 at 4:00:01 PM EST
After hours: January 3 at 4:13:15 PM EST
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-78,764.00
-78,764.00
-103,154.00
-84,782.00
-69,996.00
Investing Cash Flow
58,235.00
58,235.00
-53,578.00
54,897.00
36,991.00
Financing Cash Flow
-27,626.00
-27,626.00
198,126.00
20,033.00
3,080.00
End Cash Position
41,201.00
41,201.00
89,356.00
47,962.00
57,814.00
Income Tax Paid Supplemental Data
241.00
241.00
4,899.00
--
32.00
Interest Paid Supplemental Data
11,710.00
11,710.00
1,987.00
--
--
Capital Expenditure
-17,948.00
-17,948.00
-9,058.00
-2,125.00
-750.00
Repayment of Debt
-27,479.00
-27,479.00
--
--
--
Free Cash Flow
-96,712.00
-96,712.00
-112,212.00
-86,907.00
-70,746.00
9/30/2021 - 3/21/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TYRA Tyra Biosciences, Inc.
15.63
+8.32%
THRD Third Harmonic Bio, Inc.
11.03
-0.09%
KURA Kura Oncology, Inc.
8.73
+0.58%
PEPG PepGen Inc.
3.8300
+1.59%
PRTA Prothena Corporation plc
13.87
+1.46%
ADCT ADC Therapeutics SA
2.0200
+1.00%
CMPX Compass Therapeutics, Inc.
1.5600
+11.43%
ITOS iTeos Therapeutics, Inc.
8.15
+3.16%
FDMT 4D Molecular Therapeutics, Inc.
5.93
+1.72%
OCUL Ocular Therapeutix, Inc.
8.76
+0.23%